Search Results Search Sort by RelevanceMost Recent Case and Commentary Oct 2010 Infective Endocarditis in the Intravenous Drug User James N. Kirkpatrick, MD Patients who use drugs intravenously may be at high risk for relapse, but their situation is no more futile than that of persons with diabetes and coronary artery disease who smoke and frequent all-you-can-eat buffets. Virtual Mentor. 2010;12(10):778-781. doi: 10.1001/virtualmentor.2010.12.10.ccas1-1010. In the Literature Feb 2010 Risks and Benefits of Innovative Off-Label Surgery Caitlin E. Weber Controversy associated with off-label application of drugs and devices has arisen as innovative treatments clash with responsible regulation. Virtual Mentor. 2010;12(2):97-101. doi: 10.1001/virtualmentor.2010.12.2.jdsc1-1002. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5
Case and Commentary Oct 2010 Infective Endocarditis in the Intravenous Drug User James N. Kirkpatrick, MD Patients who use drugs intravenously may be at high risk for relapse, but their situation is no more futile than that of persons with diabetes and coronary artery disease who smoke and frequent all-you-can-eat buffets. Virtual Mentor. 2010;12(10):778-781. doi: 10.1001/virtualmentor.2010.12.10.ccas1-1010.
In the Literature Feb 2010 Risks and Benefits of Innovative Off-Label Surgery Caitlin E. Weber Controversy associated with off-label application of drugs and devices has arisen as innovative treatments clash with responsible regulation. Virtual Mentor. 2010;12(2):97-101. doi: 10.1001/virtualmentor.2010.12.2.jdsc1-1002.